Octreotide For Injectable Suspension; Good Manufacturing Practices Concerns
Octreotide for injectable suspension is being recalled across Canada due to manufacturing quality concerns. This drug is used to treat certain hormone-related conditions. The recall affects all octreotide injectable suspension products distributed in Canada.
- Product
- Octreotide for injectable suspension
- Reason
- Product quality concern
- Classification
- Class I
- Category
- drug recall
- Country
- Canada
- Agency
- HC-DRUGS
- Recall date
- 2026-01-13
- Status
- Ongoing
- Distribution
- Canada-wide
Official recall notice from HC-DRUGS
Recall details on Nibble Recalls: https://trynibble.app/recalls/3a6488b4-2c06-4a71-baf5-8ed919ae4b9d